FR2678836B1 - Formulations pour voie orale d'ubidecarenone sous la forme de solutions aqueuses. - Google Patents

Formulations pour voie orale d'ubidecarenone sous la forme de solutions aqueuses.

Info

Publication number
FR2678836B1
FR2678836B1 FR9208096A FR9208096A FR2678836B1 FR 2678836 B1 FR2678836 B1 FR 2678836B1 FR 9208096 A FR9208096 A FR 9208096A FR 9208096 A FR9208096 A FR 9208096A FR 2678836 B1 FR2678836 B1 FR 2678836B1
Authority
FR
France
Prior art keywords
ubidecarenone
aqueous solutions
oral formulations
formulations
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9208096A
Other languages
English (en)
Other versions
FR2678836A1 (fr
Inventor
Seghizzi Roberto
Furiosi Giuseppe
Martinelli Ernesto Marco
Pifferi Giorgio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IDB Holding SpA
Original Assignee
IDB Holding SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IDB Holding SpA filed Critical IDB Holding SpA
Publication of FR2678836A1 publication Critical patent/FR2678836A1/fr
Application granted granted Critical
Publication of FR2678836B1 publication Critical patent/FR2678836B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
FR9208096A 1991-07-11 1992-07-01 Formulations pour voie orale d'ubidecarenone sous la forme de solutions aqueuses. Expired - Fee Related FR2678836B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911919A IT1250672B (it) 1991-07-11 1991-07-11 Formulazioni orali di ubidecarenone in soluzione acquosa

Publications (2)

Publication Number Publication Date
FR2678836A1 FR2678836A1 (fr) 1993-01-15
FR2678836B1 true FR2678836B1 (fr) 1995-06-09

Family

ID=11360324

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9208096A Expired - Fee Related FR2678836B1 (fr) 1991-07-11 1992-07-01 Formulations pour voie orale d'ubidecarenone sous la forme de solutions aqueuses.

Country Status (6)

Country Link
EP (1) EP0522433A1 (fr)
JP (1) JPH05186340A (fr)
KR (1) KR930001903A (fr)
CH (1) CH684629A5 (fr)
FR (1) FR2678836B1 (fr)
IT (1) IT1250672B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2051643B1 (es) * 1992-10-13 1995-02-16 Inverni Della Beffa Farma Formulaciones orales de ubidecarenona en forma de soluciones acuosas.
ES2074395B1 (es) * 1993-02-25 1996-03-01 Lifepharma Srl Composicion farmaceutica o dietetica de elevada actividad antioxidante en las patologias cardiovasculares y/o hepaticas.
IT1263840B (it) * 1993-03-30 1996-09-04 Giuseppe Furiosi Formulazioni orali di ubidecarenone in forma di capsule
US6054261A (en) * 1998-05-20 2000-04-25 Q-Pharma, Inc. Coenzyme Q10 compositions for organ protection during perfusion
JP3742602B2 (ja) * 2001-05-09 2006-02-08 株式会社カネカ 還元型補酵素ｑの安定な溶液
CA2451163A1 (fr) * 2001-06-28 2003-01-09 Takeda Chemical Industries, Ltd. Medicaments destines a la prevention/au traitement de troubles fonctionnels des organes et du dysfonctionnement des organes
JP3549197B2 (ja) 2001-08-10 2004-08-04 日清ファルマ株式会社 ユビキノン含有製剤
JP3822479B2 (ja) 2001-10-10 2006-09-20 株式会社カネカ 還元型補酵素ｑ水溶液の安定化組成
JP4970734B2 (ja) * 2005-03-03 2012-07-11 株式会社コーセー 透明水性組成物
KR100859781B1 (ko) * 2007-03-26 2008-09-24 (주)미토콘 유비데카레논-함유 약학 조성물
EP2544663B1 (fr) 2010-03-12 2018-01-03 Berg LLC Formulations intraveineuses de coenzyme q10 (coq10) et leurs procédés d'utilisation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1334961A (fr) * 1961-03-06 1963-08-16 Merck & Co Inc Solutions aqueuses stables à base de benzoquinone substituée
JPS58113127A (ja) * 1981-12-28 1983-07-05 Ajinomoto Co Inc ユビデカレノン含有水性液
CH667387A5 (it) * 1985-12-24 1988-10-14 Seuref Ag Formulazioni farmaceutiche acquose di ubichinone.
JP2643217B2 (ja) * 1988-01-22 1997-08-20 エーザイ株式会社 脂溶性物質水性液

Also Published As

Publication number Publication date
ITMI911919A1 (it) 1993-01-12
IT1250672B (it) 1995-04-21
CH684629A5 (fr) 1994-11-15
FR2678836A1 (fr) 1993-01-15
KR930001903A (ko) 1993-02-22
EP0522433A1 (fr) 1993-01-13
ITMI911919A0 (it) 1991-07-11
JPH05186340A (ja) 1993-07-27

Similar Documents

Publication Publication Date Title
FR2678831B1 (fr) Compositions cosmetiques se presentant sous forme d'emulsions aqueuses d'organopolysiloxanes.
LU91290I2 (fr) Céfovécine, optionnellement sous la forme d'un sel, dont le sel de sodium (CONVENIAr)
FR2651125B1 (fr) Compositions pharmaceutiques de type "pates a l'eau".
TR199600498A2 (tr) S(+)-ibuprofen'in oral formülasyonlari.
BR9508253A (pt) formulações de risperidona aquosas
DE69007080D1 (de) Orale Hygienezusammensetzung.
IT1246188B (it) Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
MX9202413A (es) Composiciones acuosas de citrato de calcio.
TR199600499A2 (tr) S(+)-Etodolak'in oral formülasyonlari.
MA23023A1 (fr) Compositions detergentes sous forme de gel.
FR2678836B1 (fr) Formulations pour voie orale d'ubidecarenone sous la forme de solutions aqueuses.
ITMI921930A1 (it) Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda
IT1295645B1 (it) Apparecchio per l'elettroemanazione di principi attivi.
DZ2316A1 (fr) Micro sphères pharmaceutiques d'acide valproique pour administration orale.
IT1227849B (it) Composizione per l'igiene orale.
DE69815270D1 (de) Dispositif pour remplacer la plaque d'impression
IT9047924A0 (it) Composizione per l'igiene orale.
FR2759585B1 (fr) Formulations pharmaceutiques presentees sous forme seche pour l'administration orale d'un compose ammonium quaternaire cyclique
MA22516A1 (fr) Compositions cosmetiques sous forme de gels aqueux
MC2274A1 (fr) Formes d'application solides pour la voie orale qui contiennent de l'ifosfamide comme substance active
FR2677250B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.
OA09301A (fr) "Nouvelle forme galénique orale améliorant la biodisponibilité".
FR2702960B1 (fr) Leurre pour l'administration orale de médicaments vétérinaires.
FR2541114B1 (fr) Compositions pharmaceutiques antifongiques utilisables par voie orale contenant de l'omoconazole
FR2636239B1 (fr) Composition desinfectante pour la prevention de la mammite subclinique chez les ruminants

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse